Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
MET holding history
Metlife Inc in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MET overviewAll 13F holders of METFull Q2 2026 holdings
- Shares (Q2 2026)
- 95,700
- Value
- $8.10M
- % of portfolio
- 0.6%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 95,700 | $8.10M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2026 | 95,700 | $6.77M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2025 | 95,700 | $7.55M | 0.5% | −2,500−2.5% | Reduced | Holders |
| Q3 2025 | 98,200 | $8.09M | 0.7% | −74,200−43.0% | Reduced | Holders |
| Q2 2025 | 172,400 | $13.9M | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 172,400 | $13.8M | 1.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 172,400 | $14.1M | 1.2% | −168,500−49.4% | Reduced | Holders |
| Q3 2024 | 340,900 | $28.1M | 2.2% | +67,400+24.6% | Added | Holders |
| Q2 2024 | 273,500 | $19.2M | 1.6% | −22,100−7.5% | Reduced | Holders |
| Q1 2024 | 295,600 | $21.9M | 1.5% | +1,300+0.4% | Added | Holders |
| Q4 2023 | 294,300 | $19.5M | 1.4% | +46,000+18.5% | Added | Holders |
| Q3 2023 | 248,300 | $15.6M | 1.2% | +248,300 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −240−100.0% | Sold out | Holders |
| Q1 2023 | 240 | $14.0K | <0.1% | −484,400−100.0% | Reduced | Holders |
| Q4 2022 | 484,640 | $35.1M | 1.9% | 00.0% | Unchanged | Holders |
| Q3 2022 | 484,640 | $29.5M | 1.7% | +9,500+2.0% | Added | Holders |
| Q2 2022 | 475,140 | $29.8M | 1.8% | −15,400−3.1% | Reduced | Holders |
| Q1 2022 | 490,540 | $34.5M | 1.7% | +147,200+42.9% | Added | Holders |
| Q4 2021 | 343,340 | $21.5M | 1.0% | +343,340 | New | Holders |